3 hours Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Average Rating of “Buy” by Brokerages MarketBeat
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are presently covering the company, MarketBeat Ratings reports. Six investment analysts have rated the …